Thompson A - Search Results

1

Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapse.

Palmieri C, Monteverde M, Lattanzio L, Gojis O, Rudraraju B, Fortunato M, Syed N, Thompson A, Garrone O, Merlano M, Lo Nigro C, Crook T. Palmieri C, et al. Among authors: thompson a. Br J Cancer. 2012 Aug 7;107(4):732-8. doi: 10.1038/bjc.2012.308. Epub 2012 Jul 10. Br J Cancer. 2012. PMID: 22782348 Free PMC article.

2

Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.

Thompson AM, Kerr DJ, Steel CM. Thompson AM, et al. Br J Cancer. 1991 Apr;63(4):609-14. doi: 10.1038/bjc.1991.140. Br J Cancer. 1991. PMID: 2021547 Free PMC article.

3

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.

Thompson AM, Steel CM, Chetty U, Hawkins RA, Miller WR, Carter DC, Forrest AP, Evans HJ. Thompson AM, et al. Br J Cancer. 1990 Jan;61(1):74-8. doi: 10.1038/bjc.1990.17. Br J Cancer. 1990. PMID: 2137009 Free PMC article.

4

Gene expression in oestrogen-dependent human breast cancer xenograft tumours.

Thompson AM, Steel CM, Foster ME, Kerr D, Paterson D, Deane D, Hawkins RA, Carter DC, Evans HJ. Thompson AM, et al. Br J Cancer. 1990 Jul;62(1):78-84. doi: 10.1038/bjc.1990.233. Br J Cancer. 1990. PMID: 2390487 Free PMC article.

5

Critical determination of the frequency of c-erbB-2 amplification in breast cancer.

Hubbard AL, Doris CP, Thompson AM, Chetty U, Anderson TJ. Hubbard AL, et al. Among authors: thompson am. Br J Cancer. 1994 Sep;70(3):434-9. doi: 10.1038/bjc.1994.323. Br J Cancer. 1994. PMID: 7915911 Free PMC article.

6

Expression of transforming growth factor beta mRNA isoforms in human breast cancer.

MacCallum J, Bartlett JM, Thompson AM, Keen JC, Dixon JM, Miller WR. MacCallum J, et al. Among authors: thompson am. Br J Cancer. 1994 Jun;69(6):1006-9. doi: 10.1038/bjc.1994.197. Br J Cancer. 1994. PMID: 8198961 Free PMC article.

7

Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer.

Thompson AM, Morris RG, Wallace M, Wyllie AH, Steel CM, Carter DC. Thompson AM, et al. Br J Cancer. 1993 Jul;68(1):64-8. doi: 10.1038/bjc.1993.287. Br J Cancer. 1993. PMID: 8318422 Free PMC article.

8

pS2 is an independent factor of good prognosis in primary breast cancer.

Thompson AM, Hawkins RA, Elton RA, Steel CM, Chetty U, Carter DC. Thompson AM, et al. Br J Cancer. 1993 Jul;68(1):93-6. doi: 10.1038/bjc.1993.292. Br J Cancer. 1993. PMID: 8318427 Free PMC article.

9

PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer.

Thompson AM, Elton RA, Hawkins RA, Chetty U, Steel CM. Thompson AM, et al. Br J Cancer. 1998;77(3):492-6. doi: 10.1038/bjc.1998.78. Br J Cancer. 1998. PMID: 9472649 Free PMC article.

10

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.

Thompson AM, Crichton DN, Elton RA, Clay MF, Chetty U, Steel CM. Thompson AM, et al. Br J Cancer. 1998 Mar;77(5):797-800. doi: 10.1038/bjc.1998.129. Br J Cancer. 1998. PMID: 9514060 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,978 results

Search Page

Filters